Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Bioniche Life Sciences Inc. Stories

2014-04-15 20:23:13

LURE, FRANCE and BELLEVILLE, ON, April 15, 2014 /PRNewswire/ - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche's Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in...

2014-04-14 12:36:38

BELLEVILLE, ON, April 14, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that its shareholders have voted in favour of the sale of the Company's Animal Health business to Vétoquinol SA. At a Special Meeting of Shareholders held this morning in Toronto, 39.4% of the issued and outstanding shares were voted, with 97.4% of those voting in favour of the sale transaction. The transaction is expected to close tomorrow. About Bioniche Life Sciences...

2014-04-03 16:24:27

BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it has successfully monetized two non-core properties for net proceeds in excess of $1 million. Over the past several months, the Board of Directors and management team have developed and have been implementing a strategic expenditures review which included identifying and divesting non-core assets. The sale of the property adjacent to the Company's Belleville, Ontario...

2014-04-03 12:29:32

BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that Institutional Shareholder Services (ISS) has recommended that shareholders vote FOR the special resolution pertaining to the sale of all of the Corporation's Animal Health business to Vétoquinol SA, to be considered at the upcoming Special Meeting of Shareholders: Monday, April 14, 2014 9:00 .m. EST Norton Rose Fulbright Canada Board Rooms D, E, and F Royal Bank Plaza, South...

2014-03-13 20:24:06

BELLEVILLE, ON, March 13, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today held a conference call and audio webcast for its shareholders, at which time, Company representatives provided several corporate updates. The corporate presentation used during today's call/webcast is available on the Company's website (www.Bioniche.com) under Investors - Corporate Presentations. Sale Transaction of Bioniche Animal Health to Vétoquinol The Company outlined some of the...

2014-03-04 08:33:11

BELLEVILLE, ON, March 4, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) announced today key corporate updates: -- The establishment of Monday, April 14, 2014 as the date of the Shareholder Meeting for consideration of the C$61 million acquisition offer for Bioniche's Animal Health business; -- The scheduling of a Shareholder Conference Call on Thursday, March 13, 2014, with Bioniche CEO, Dr. Michael Berendt, to...

2014-02-27 16:28:54

LURE, FRANCE and BELLEVILLE, ON, Feb. 27, 2014 /PRNewswire/ - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million. This agreement remains subject to the approval by shareholders of Bioniche Life Sciences Inc., and the usual closing conditions for a...

2014-02-06 12:28:22

(all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, Feb. 6, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC), a leading clinical stage biotechnology company, today announced financial results for the second quarter of Fiscal 2014 (ended December 31, 2013). Highlights include: -- Bioniche Animal Health generated 100% year-over-year EBITDA increase; -- Negotiations continuing for the sale of the Animal Health...

2014-01-07 16:25:42

BELLEVILLE, ON, Jan. 7, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a leading clinical stage biotechnology company, today announced the appointment of Donald Olds as Chief Operating Officer, effective immediately. Dr. Michael Berendt, CEO of Bioniche Life Sciences Inc., highlighted that, "the engagement of Donald Olds as Chief Operating Officer is the next step in our operational plan to position Bioniche Life Sciences as a top-tier North American...

2013-12-11 16:25:08

BELLEVILLE, ON, Dec. 11, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC, ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announces that the Australian Securities Exchange (ASX) has approved the Company's application to delist from the official list of the ASX subject to certain usual conditions. The conditions include the requirement to communicate to all holders of CHESS Depositary Interests (CDIs) advising of the date of...